National Health (Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 2014 (PB 68 of 2014)

Administered by Department of Health, Disability and Ageing

Legislation au F2014L01302 Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

National Health Act 1953

 

National Health (Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 2014

 

PB 68 of 2014

 

Authority

 

Subsection 100(1) of the National Health Act 1953 (the Act) enables the Minister to make special arrangements for the supply of pharmaceutical benefits. Subsection 100(2) of the Act provides that the Minister may vary or revoke a special arrangement made under subsection 100(1).

 

Subsection 100(3) of the Act provides that Part VII of the Act, and instruments made for the purposes of Part VII of the Act have effect subject to a special arrangement made under subsection 100(1). 

 

Purpose

 

The purpose of this instrument is to allow three private hospitals located in Victoria to use electronic and paper medication charts to prescribe and claim pharmaceutical benefits.

 

The approved suppliers supply pharmaceutical benefits using paper copies of the medication charts and then submit claims to the Chief Executive Medicare without paper copies of the medication charts. The approved suppliers must then create electronic records of the medication charts which are stored for not less than two years to facilitate auditing by the Chief Executive Medicare if necessary.

 

This Special Arrangement revokes and replaces the National Health (Epworth Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 2014. The revoked special arrangement only authorised trial participation by Epworth Eastern hospital and Epworth Freemason’s hospital (at its two addresses). This Special Arrangement extends the trial to an additional private hospital in Victoria, Cabrini Brighton.

 

The Department expects that the results of the trial will contribute to the development of national eHealth policy, and more specifically medication chart specifications which are currently being developed through the Medication Charts in Public and Private Hospitals Initiative.  

 

Consultation

The Department of Health consulted with the Department of Human Services, the participating hospitals and their approved suppliers during the development of this Instrument. As a result of these consultations all parties are satisfied with the outcomes and terms and conditions of the Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial.

A provision by provision description of this Special Arrangement is contained in the Attachment.

 

This Special Arrangement commences on 1 October 2014.

 

This instrument is a legislative instrument for the purposes of the Legislative Instruments Act 2003.

 

 

ATTACHMENT

 

PROVISION BY PROVISION DESCRIPTION OF THE NATIONAL HEALTH (EPWORTH AND CABRINI PRIVATE HOSPITALS PAPERLESS PRESCRIBING AND CLAIMING TRIAL) SPECIAL ARRANGEMENT 2014 (PB 68 of 2014)

 

Section 1 Name of Special Arrangement

 

This section provides that the Special Arrangement is the National Health (Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 2014 and that it may also be cited as PB 68 of 2014.

 

Section 2 Commencement

 

This section provides that the Special Arrangement commences on 1 October 2014.

 

Section 3 Revocation

 

This section revokes instrument PB 16 of 2014, the special arrangement authorising the Epworth Private Hospital Paperless Prescribing and Claiming Trial.

 

Section 4 Definitions

 

This section defines a number of expressions that are used in the Special Arrangement, including ‘approved supplier’, ‘hospital’ and ‘in-patient of the hospital’.

 

Section 5 Application of Part VII of the Act

 

Subsection 100(3) of the Act provides that Part VII of the Act, and regulations or other instruments made for the purposes of Part VII have effect subject to a special arrangement made under subsection 100(1).

 

Section 5 provides that the pharmaceutical benefits supplied under this Special Arrangement are supplied under Part VII. This is the situation under the Act and this section confirms that this is not intended to be modified by the Special Arrangement.

 

Section 6 Pharmaceutical benefits covered by this Special Arrangement

 

This section provides for the pharmaceutical benefits that are covered by this Special Arrangement. The pharmaceutical benefits covered are all pharmaceutical benefits except those that are supplied only under another special arrangement.

 

Section 7 Prescribing of Pharmaceutical Benefits

 

This section provides for the circumstances in which a medication chart prepared by a PBS prescriber will be taken to be a validly written prescription and the information that the PBS prescriber needs to include on a medication chart. This modifies the requirements for a prescription in Regulation 19 of the National Health (Pharmaceutical Benefits) Regulations 1960 (the Regulations).

 

This section also provides limitations on prescribing using medication charts. PBS prescribers are not allowed to direct a repeated supply or supply all on one occasion. If they direct a repeated supply that direction is invalid. If they direct supply all on one occasion on a medication chart it is deemed to be a direction to supply the maximum quantity for that pharmaceutical benefit determined under paragraph 85A(2)(a) of the Act. PBS prescribers are also not allowed to prescribe a pharmaceutical benefit requiring an authority prescription using a medication chart.

 

Section 8 Supply and Claiming of Pharmaceutical Benefits

 

This section provides that this Special Arrangement applies to approved suppliers listed in column 2 of the Schedule to this Special Arrangement when supplying pharmaceutical benefits to in-patients of the hospitals listed in column 1 of the Schedule to this Special Arrangement.

 

This section provides that an approved supplier cannot defer the supply of any pharmaceutical benefit supplied under this Special Arrangement. This section also modifies the requirements in Regulation 31 of the Regulations for eligible persons to confirm receipt of pharmaceutical benefits and date of supply by allowing an approved supplier to certify on a medication chart that the in-patient of the hospital has received the pharmaceutical benefit/s prescribed on the medication chart.

 

This section also provides for the keeping of electronic pharmacy records of pharmaceutical benefits supplied under this Special Arrangement where the approved supplier is making a claim under section 99AAA of the Act. The Chief Executive Medicare can request a copy of electronic pharmacy records or medication charts for pharmaceutical benefits supplied under this Special Arrangement.

 

This section also provides that approved suppliers are required to submit claim and under co-payment data to the Chief Executive Medicare as required by the rules under subsections 99AAA(8) and 98AC(4) of the Act.

 

Section 9 Transitionals

 

This section provides transitional arrangements so that the approved supplier for the Epworth Private Hospitals can make a valid claim where pharmaceutical benefits prescribed under the previous special arrangement for the Epworth Private Hospitals have not been supplied prior to    1 October 2014.

 

The Schedule

 

The Schedule provides the name and address of the hospitals participating in this Special Arrangement and the name, address and approval number of the approved suppliers associated with the hospitals participating in this Special Arrangement.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Overview

The National Health (Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 2014 was enacted to address the gap in existing pharmaceutical benefit regulations, specifically allowing three private hospitals in Victoria to use electronic and paper medication charts for prescribing and claiming pharmaceutical benefits. This Special Arrangement, made under subsection 100(1) of the National Health Act 1953, was introduced to trial the use of electronic and paper medication charts as valid prescriptions, thereby extending the previous trial involving only Epworth Eastern and Epworth Freemason’s hospitals to include Cabrini Brighton hospital. The policy objective is to facilitate the development of national eHealth policy, particularly medication chart specifications, by gathering trial data that can inform future policy decisions. The Department of Health consulted with the Department of Human Services, the participating hospitals, and their approved suppliers to ensure all parties were satisfied with the trial's terms and conditions. This arrangement commenced on 1 October 2014 and operates under Part VII of the National Health Act 1953, modifying certain prescription requirements and supply processes to accommodate the trial's unique circumstances.

Scope and Application

The National Health (Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 2014 applies to the Epworth and Cabrini Private Hospitals in Victoria and their approved suppliers, who are permitted to use both electronic and paper medication charts to prescribe and claim pharmaceutical benefits. This Special Arrangement is authorised under subsection 100(1) of the National Health Act 1953, and it modifies the requirements for prescribing and claiming pharmaceutical benefits for the purposes of the trial. The arrangement extends the previous trial, which only involved the Epworth Eastern and Epworth Freemason’s hospitals, to include the Cabrini Brighton hospital. It revokes the earlier special arrangement and sets out new terms and conditions for the trial. The Special Arrangement is subject to the overarching provisions of the National Health Act 1953, which regulates the supply of pharmaceutical benefits, and it modifies certain regulations to facilitate the trial. Any approved supplier participating in the trial must adhere to the specified requirements, including the creation and retention of electronic records of medication charts and the submission of claims and co-payment data to the Chief Executive Medicare. The Special Arrangement is intended to contribute to the development of national eHealth policy and medication chart specifications.

Key Provisions

The main operative sections of the National Health (Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 2014 (PB 68 of 2014) include the authority under which it is made (subsection 100(1) of the National Health Act 1953), the purpose of the arrangement (to allow electronic and paper medication charts for prescribing and claiming pharmaceutical benefits), and the commencement date (1 October 2014). The Special Arrangement revokes the previous trial arrangement and extends it to include an additional hospital, Cabrini Brighton, in addition to the two Epworth hospitals. The Special Arrangement defines key terms such as 'approved supplier' and 'hospital', specifies the pharmaceutical benefits covered, and outlines the conditions for valid prescribing and claiming of pharmaceutical benefits under the trial. The Special Arrangement imposes several obligations and requirements on the parties involved. Approved suppliers must create electronic records of the medication charts and store them for at least two years to facilitate auditing by the Chief Executive Medicare. Suppliers are not allowed to defer the supply of any pharmaceutical benefit and must certify on a medication chart that the in-patient has received the prescribed pharmaceutical benefit. Approved suppliers must also submit claims and co-payment data to the Chief Executive Medicare as required by the Act. Additionally, the approved suppliers must comply with the limitations on prescribing using medication charts, including not directing a repeated supply or supply all on one occasion, and not prescribing a pharmaceutical benefit requiring an authority prescription using a medication chart. There are no specific offences, penalties, or civil/criminal consequences outlined in the Special Arrangement for breach of its provisions. However, failure to comply with the requirements for auditing, record-keeping, and data submission could potentially result in penalties under the broader provisions of the National Health Act 1953. For instance, non-compliance with the Act’s requirements could lead to administrative actions, financial penalties, or other sanctions as deemed appropriate by the Minister or relevant authorities.

Legal classification tags

Area of Law
Health Law
Pharmaceutical Law
Instrument
Special Arrangement
Concepts
Definitions & Interpretation
Pharmaceutical benefits covered by this Special Arrangement
Prescribing of Pharmaceutical Benefits
Supply and Claiming of Pharmaceutical Benefits
Transitionals
Catchwords
Electronic and paper medication charts
Approved suppliers
Pharmaceutical benefits

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.